Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) Chemotherapy in the Treatment of Metastatic or Unresectable Locally Recurrent Anal Squamous Cell Carcinoma: A Phase II Study of French Interdisciplinary GERCOR and FFCD Groups (Epitopes-Hpv02 Study)

BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3566-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Phase II Study of Docetaxel and Irinotecan Combination Chemotherapy in Metastatic Gastric Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2006English

A Phase II Evaluation of a 3-Hour Infusion of Paclitaxel, Cisplatin, and 5-Fluorouracil in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Cancer
Cancer ResearchOncology
2006English

Weekly Chemotherapy of 5‐Fluorouracil Plus Cisplatin Concurrent With Radiotherapy for Esophageal Squamous Cell Carcinoma Patients With Postoperative Locoregional Recurrence: Results From a Phase II Study

Oncologist
Cancer ResearchMedicineOncology
2019English

Induction With Mitomycin C, Doxorubicin, Cisplatin and Maintenance With Weekly 5-Fluorouracil, Leucovorin for Treatment of Metastatic Nasopharyngeal Carcinoma: A Phase II Study

British Journal of Cancer
Cancer ResearchOncology
1999English

Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/Ii Clinical Study

Oncologist
Cancer ResearchMedicineOncology
2016English

A Phase II Study of Temsirolimus and Erlotinib in Patients With Recurrent and/or Metastatic, Platinum-Refractory Head and Neck Squamous Cell Carcinoma

Oral Oncology
Cancer ResearchOral SurgeryOncology
2013English

Adoptive T-Cell Transfer and Chemotherapy in the First-Line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

A Phase II Study of Axalimogene Filolisbac for Patients With Previously Treated, Unresectable, Persistent/Recurrent Loco-Regional or Metastatic Anal Cancer

Oncotarget
Oncology
2020English

SWOG 0514: A Phase II Study of Sorafenib in Patients With Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma

Investigational New Drugs
OncologyPharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy